SlideShare a Scribd company logo
Prepared by:
HIMIKA RATHI
EPILEPSY
What is EPILEPSY?
Epilepsy is a chronic CNS disorder characterized by brief episodes of
Seizure is a sudden time limited involuntary alteration of behavior
with or without loss of consciousness accompanied by an
2
Pathophysiology of EPLILEPSY
• Each individual neuron is linked with hundreds of other neuron via
synapses.
• Neurons discharge electrical current and neurotransmitters are
released at synaptic levels and permits inter-communication.
• There are two types of Neurotransmitters:
1. Inhibitory Neurotransmitters: GABA (Gamma amino butyric acid)
acts on ion channels and increases chloride outflow and decreases
chances of action potential.
2. Excitatory Neurotransmitters: Glutamate and Aspartate allows
sodium and calcium influx which paves way for action potential
formation.
• Seizures occur due to the imbalance between the inhibitory and
excitatory Neurotransmitters.
• A normal neuron discharges repetitively at low baseline frequencies.
If neurons are damaged, injured/ suffer a chemical/ metabolic insult,
the changes in discharge pattern develops.
• During epilepsy, regular low frequency discharges are replaced by
bursts of high frequency discharges followed by periods of inactivity.
• A single Neuron discharging in an abnormal manner is usually not
clinically significant. But when a whole population of neurons
discharge synchronously in an abnormal manner, epileptic seizure
occurs.
Causes of EPLILEPSY
• In 28% cases, cause can be determined, in rest 72% cases, cause is
idiopathic.
• Determined causes:
1) Inherited genetic
2) Acquired: Trauma, Metabolic infections, Tumour, Neuro surgery,
Drugs, etc.
of inhibitory neurotransmitter such as the
4) Increase excitatory neurotransmitter.
5) Concentration of is reversed.
6) Abnormality in the potassium conductance.
7) Defect in the voltage sensitive channel
6
Drugs that Induces Seizures
• Alcohols: ethanol, ethylene glycol, methanol, propylene glycol
• Anesthetics: bupivacaine, cocaine, lidocaine, procaine, proparacaine,
enflurane, etomidate, isoflurane, ketamine.
• Antibiotics: cephalosporins,ciprofloxacin, gentamicin, cilastatin,
isoniazid
• Anticholinergics: atropine, benztropine mesylate, diphenhydramine
• Antidepressants: amitriptyline, amoxapine, clomipramine,
desipramine,doxepin
• Antihistamines: astemizole, brompheniramine, chlorpheniramine,
diphenhydramine, doxylamine
• Antineoplastics: bleomycin, busulphan, carmustine, chlorambucil,
cisplatin,cytarabine,mechlorethamine
• Antiparasitics: chloroquine, oxamniquine, pyrimethamine
• Antivirals: acyclovir, amantadine
• Asphyxiants: acetylene, butane, carbon dioxide, ethane
• Cardiovascular Agents: aprindine, digoxin, lidocaine, lorcainide.
• Drugs Of Abuse: amphetamines, cocaine, lysergic acid diethylamide
(LSD), marijuana, methamphetamine ("ice"), phencyclidine (PCP)
• Drug Withdrawal: anticonvulsants,barbiturates, benzodiazepines
Diagnosis
• Neurological examination/ Neuropsychological Tests
• Medical history
• Genetic Testing
• Electroencephalogram (EEG)
• CT Scan/ MRI Scan
• fMRI
• Positron Emission Tomography (PET Scan)
• SPECT (Single Photon Emission Computerized Tomography)
• SISCOM (Subtraction Ictal SPECT categorized to MRI)
Types of
epilepsy
Generalized
seizures
Tonic – clonic
seizure (Gran
mal seizure)
Absence
seizure
(petit mal
seizure)
Atonic
seizure
Myoclonic
seizure
Localized (partial
or focal)
Simple partial
seizure
(jacksoninan)
Complex partial
(psychomotor)
seizure
10
Types of EPLILEPSY
• Generalized seizures
1.Tonic-clonic seizures(Major epilepsy,
Grand mal)
• Lasts 1-2 min
• Usual sequences is aura-cry-
unconsciousness-tonic of all
body muscles-clonic followed by
prolong sleep
• Stiffening of arms and legs followed by
rhythmic jerking.
Types of EPLILEPSY
2. Absence siezures (Minor epilepsy, Petit
mal)
• Lasts about 1-2 min
• Momentary loss of consciousness
• Little jerking
• Often subside prior to puberty.
Types of EPLILEPSY
3. Atonic seizures (Akinetic epilepsy)
• Unconsciousness with relaxation of all
muscles
• Due to excessive
• Patient may fall , after 10 seconds to a
minute, they recover and regain
consciousness and can stand and walk
again.
Types of EPLILEPSY
4. Myoclonic seizures
of
muscles of limb or the whole body
• Juvenile myoclonic epilepsy (JME) is
the most common form of this
condition.
Types of Epilepsy
• Simple partial seizure(Cortical focal epilepsy)
oLasts 1/ 1-2 min
oConvulsion are of muscles or localized sensory
disturbance depending on the area of cortex involved in seizure
oWithout loss of consciousness
oComplex partial seizure(Temporal lobe epilepsy, Psychomotor
epilepsy)
oAttack of bizarre and and purposeless movement
oEmotional changes lasting 1-2 min along with impairment of
consciousness.
oThe seizure focus is located in the temporal lobe.
15
TYPES OF TREATMENT
16
• Medication
• Surgery
• Non-pharmacologic treatment
1. Ketogenic diet
2. Vagus nerve stimulation (VNS)
3. Lifestyle modifications
CLASSIFICATION
1. Barbiturate: Phenobarbitone
2. Deoxybarbiturate: Primidone
3. Hydantoin: Phenytoin, Fosphenytoin
4. Iminostilbene: Carbamazepine, Oxcarbazepine
5. Succinimide: Ethosuximide
6. Aliphatic carboxylic acid: Valproic acid (sodium valproate)
7. Benzodiazepines: Clonazepam, Diazepam, Lorazepam,
Clobazam
8. Phenyltriazine: Lamotrigine
9. Cyclic GABA analogue: Gabapentin
10. Newer drugs: Vigabatrin, Topiramate, Tiagabine, Zonisamide,
Levetiracetam
17
CLASSIFICATION
• Group 1- Blockade of voltage-dependent Na+ or Ca channels
(generalised and partial seizures)
• Group 2- Enhance inhibitory events mediated by GABA (absence,
generalised, partial seizures)
• Group 3- Blocks T-type calcium channels (absence seizures).
• Group X- Reduce events mediated by excitatory amino acid glutamate
Sodium
Channel
Calcium
Channel
GABAERGIC
Phenytoin
Carbamazepine
Oxcarbazepine
Zonisamide
Lamotrignine
Ethosuximide Benzodiazepines
Barbiturates
Tiagabine
Vigabatrine
Gaba pentin
Glutamate CA inhibitor Other
Felbamate
Topiramate
Acetazolamide Levetiracetam
Progesterone
Group 1- Blockade of voltage-dependent Na+ or Ca
channels (generalised and partial seizures)
20
Carbamazepine
Clinical uses:
• Primary generalized tonic clonic seizures.
• Partial seizures with or without secondarily generalization.
• Bipolar disorders.
• Chronic pain syndromes: Trigeminal neuralgia.
Pharmacokinetics:
• Initial half-life is 20- 40 hrs but decreases to 20-40 hr on chronic
medication.
• Active metabolite: 10-11 epoxy carbamazepine.
Carbamazepine
Dose:
• Available only in oral form.
• Effective in children, in whom a dosage of 15-25 mg/kg/d is appropriate.
• In adults, daily doses of 1 g or even 2 g are tolerated.
Neurotoxic side effects :
• Blurred or double vision
• Lethargy, headache.
• Worsening of myoclonic, Atonic & absence seizures.
Carbamazepine
Systemic side effects :
• Nausea, vomiting, diarrhea
• Hyponatremia & fluid retention.
• Rash, pruritus
Rare side effects :
• Blood dyscrasias: Agranulocytosis, aplastic anemia.
• Dermatitis/rash
• Stevens-Johnson syndrome.
• Serum sickness, pancreatitis
• Hepatic failure
Phenytoin
Clinical uses :
• Partial & generalized tonic clonic seizures.
• 2nd line agent for patients with mixed seizures (myoclonic/tonic-
clonic).
• Status epilepticus.
Neurotoxic Side effects:
• Dose related : Diplopia & Ataxia.
• Peripheral neuropathy.
• Behavior changes.
Phenytoin
Systemic side effects :
• Skin rash
• Lymphadenopathy ( abnormally enlarged lymph nodes)
• Gingival hyperplasia
• Pulmonary fibrosis
• Hirsutism
• Teratogenic ( Fetal Hydantoin syndrome includes cleft lip and palate,
congenital heart disease)
• Megaloplastic anemia ( folate deficiency ).
NOTE – phenytoin is also an anti-arrthymetic drug treatment with
phenytoin should not be stopped abruptly.
Lamotrigine
Decreases the release of excitatory neurotransmitters
(glutamate/aspartate).
Clinical uses :
• Monotherapy in partial seizures
• Adjunctive therapy in generalized tonic clonic seizure
• Mixed seizures
Side effects :
• Dizziness, headache, Diplopia
• Nausea
• Hypersensitivity skin rash
not to be used in those < 16 years
Oxcarbazepine
It is a 10- keto analogue to carbamazepine.
Clinical uses:
• Partial seizures
• Generalized tonic clonic seizures
• Affective disorders
• Trigeminal neuralgia
Side effects :
• CNS : sedation, dizziness, ataxia, diplopia
• Hyponatremia but less less than carbamazepine
• Allergic skin reaction
Zonisamide
• Sulfonamide derivatives.
• Blocking of voltage dependent Na & T- type Ca channels.
• Partial & Generalized tonic clonic seizures.
• Useful against infantile spasm and certain types of myoclonias.
Side effects :
• CNS: confusion, ataxia, sedation, poor concentration
• Anorexia & weight loss
• Skin rash
• decreased sweating, hyperthermia
• Renal stones (rare)
C/I : Allergy to sulfonamides.
• Group 2- Enhance inhibitory
events mediated by GABA
(absence, generalised, partial
seizures)
29
Phenobarbital
M.O.A :
• Binds to GABA receptor improving its effect by extending GABA
mediated chloride channel opening.
Clinical uses:
• Partial seizures
• Generalized tonic clonic seizures
• Neonatal seizures
• Status epilepticus
Side effects:
• Sedation, ataxia, nystagmus ( rapid, rhythmic and involuntary eye
movements), vertigo
• Agitation & confusion, at high doses.
• Alteration of sleep cycles
Gabapentin
It is an amino acid, an analogue to GABA.
Clinical uses:
• Partial seizures
• Generalized tonic clonic seizures
• Neuropathic pain: post herpetic neuralgia
Side effects:
• CNS: sedation, ataxia, headache, tremor
• GI upset.
• Weight gain.
Tiagabine
Inhibition of GABA reuptake into presynaptic neurons.
Clinical uses:
• Adjunctive treatment for partial and generalized seizures
Side effects:
• CNS: sedation, tremor, depression, confusion
• Nausea, abdominal pain
• Not recommended in children under age of 12 years.
Vigabatrin
• Irreversible inhibitor of GABA transaminase.
Clinical uses:
• 2nd line treatment in patients with refractory partial seizures
• 1st line treatment in infantile spasm (west’s syndrome)
• May worsen myoclonic jerks and generalized absence and precipitate
status epilepticus
Side effects :
• CNS: sedation, dizziness, headache
• Change in mood, agitation
• Retinal toxicity… irreversible
• Weight gain
Clonazepam
Clinical uses
• Myoclonic seizures
• Generalized seizures (mainly absence)
• Status epilepticus
• Infantile spasm
Side effects:
• Sedation, ataxia, irritability.
• Cardiovascular & Respiratory depression .
• Hyper salivation in pediatric .
• Idiosyncratic reaction like blood dyscrasia is rare.
Group 3- Blocks T-type calcium channels (absence seizures).
35
Ethosuximide
• Reduces T- type calcium currents in thalamic neurons
• Effective against absence seizures
• May increase tonic- clonic seizures
Side effects :
• Nausea & Vomiting.
• Sleep disturbances.
• Drowsiness & Hyperactivity.
Drugs With Multiple Mechanisms Of
Actions
● Valproate
● Felbamate
● Topiramate
Valproate
M.O.A:
• Blocking voltage- dependent sodium channels
• Enhances GABA synthesis
• Inhibits GABA transaminase
• Acts against T- type calcium current
Clinical uses:
• Absence seizures
• Generalized tonic clonic seizures
• Bipolar disorders
• Migraine prophylaxis
Valproate
Side effects:
• CNS: Tremor
• Dose related GI symptoms
• Increase appetite & weight gain
• Hair loss
• Hepatotoxicity esp. < 2 years.
• Thrombocytopenia
• Teratogenic, spina bifida ( major birth defect, type of neural tube defect
Felbamate
M.O.A:
• Inhibition of voltage – dependent sodium channels
• Potentiate GABA response at GABA receptors
• Inhibition of the excitatory N-methyl-D-aspartate (NMDA)
receptors
Clinical uses:
• Broad spectrum of action
• Effective in some patients with partial seizures
• 3rd line drug in refractory seizures- in lennox gastaut syndrome
Side effects:
• CNS: Insomnia, Diplopia, Ataxia
• Weight loss.
Topiramate
M.O.A:
• Blockage voltage – dependent sodium channels
• Enhances activity of GABA at non benzodiazepine
• Site on GABA (A) receptors
• Antagonizes NMDA receptors
• Weakly inhibits carbonic anhydrase enzyme
Clinical uses:
• Adjunctive therapy for partial & generalized seizures
• Adjunctive therapy for Lennox-Gastaut syndrome & infantile spasm
Topiramate
Side effects:
• CNS: confusion, ataxia, poor concentration
• Cognitive impairment
• Visual disorders: myopia, glaucoma (rare)
• Weight loss
• Parasthesia & renal stones due to inhibition of carbonic anhydrase
enzyme.
• Teratogenic in animals
Drugs With Unknown Mechanism Of
Actions
Levetiracetam:
• Broad spectrum
• Add- on therapy for refractory partial seizures
Side effects:
• CNS: Fatigue, dizziness, agitation, anxiety
• Increases susceptibility to infection, rhinitis or flu like symptoms
• Anemia, leukopenia
Pregabalin
Clinical uses:
• Adjunctive therapy for partial seizures
• Peripheral neuropathic pain.
Renally excreted and is not hepatically metabolized
Side effects :
• Dizziness, somnolence and ataxia
• Blurred or double vision
• Weight gain
• Peripheral edema
• May cause euphoria
• New onset myoclonus has been reported
ECT
45
• Electroconvulsive therapy (ECT), formerly known as electroshock
therapy, and often referred to as shock treatment, is
a psychiatric treatment in which seizures are electrically induced in
patients to provide relief from mental disorders.
KETOGENIC DIET
46
• Based on finding that starvation, which burns fat for energy has an
antiepileptic effect
• Used primarily to treat severe childhood epilepsy, has been effective in
some adults & adolescents
• High fat, low carbohydrate and protein intake
• Requires strong family commitment
VAGUS NERVE STIMULATION
47
• Device is implanted to control seizures by delivering
electrical stimulation to the vagus nerve in the neck, which
relays impulses to widespread areas of the brain.
• Used to treat partial seizures when medication does not
work.
COMMON CAUSES OF FAILURE OF
ANTIEPILEPTICS
1. Improper diagnosis of the type of seizures
2. Incorrect choice of drug
3. Inadequate or excessive dosage
4. Poor compliance
48
TREATMENT IN SPECIAL
SITUATIONS
ANTIEPILEPTIC AND PREGNANCY :
• Seizures are very harmful for pregnant women.
• Monotherapy usually better than drugs combination.
• Folic acid is recommended to be given for every pregnant
women with epilepsy.
• Phenytoin, sodium valproate are absolutely contraindicated and
oxcarbamazepine is better than carbamazepine.
49
EPILEPSY IN ADOLESCENTS AND YOUNG
ADULTS
Important points to remember are:
• Avoiding sleep deprivation,
• alcohol and substance abuse, driving, potentially risky leisure activities
like rock climbing, horse riding, etc.
• Prolonged television (TV) viewing, playing video games and dancing
in dark rooms with flickering/flashing lights (discotheques).
50
SURGERY IN EPILEPSY
• All patients with medically intractable epilepsy (MIE) should be
evaluated at a center performing epilepsy surgery.
• A patient having MIE with an identifiable lesion on imaging, correlated
with electrophysiology [Electroencephalogram (EEG)] is a potential
candidate for epilepsy surgery. Even if imaging is negative, patients
still can be surgical candidates on further investigation.
• Epilepsy surgery should be done only in specialized centers.
• Surgery has a high chance of achieving seizure freedom (in 60– 70% of
cases) and a reduction in seizure frequency in the remaining 30–40%
cases.
• When indicated it should be considered as early as feasible rather than
an option of last resort.
51
SURGERY IN EPILEPSY
• Epilepsy surgery may be resective or nonresective.
• Resective surgery includes lesionectomy (resection of the lesion and
the surrounding epileptogenic area), amygdalohippocampectomy with
or without temporal lobe resection, multilobar resection and
hemispherectomy.
• Nonresective surgery includes multiple subpial transections corpus
colostomy and vagus nerve stimulation (VNS).
52
Summary
Pathophysiology
Decrease in INT/Increase in ENT/Abnormalities in Ion channel
Rhythmic and repetitive hyper synchronous discharge of neuron
Seizures
Repetitive Seizures
Epilepsy
55
57
63

More Related Content

Similar to epilepsy-210211104538.pdf

cns-antiepileptics.pdf
cns-antiepileptics.pdfcns-antiepileptics.pdf
cns-antiepileptics.pdf
MohammadShafique24
 
cns-antiepileptics.pdf
cns-antiepileptics.pdfcns-antiepileptics.pdf
cns-antiepileptics.pdf
MohammadShafique24
 
cns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptxcns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptx
shyam sunder
 
recent advances in antiepileptics
recent advances in antiepilepticsrecent advances in antiepileptics
recent advances in antiepilepticspriyanka527
 
Antiepileptic Drugs.pptx
Antiepileptic Drugs.pptxAntiepileptic Drugs.pptx
Antiepileptic Drugs.pptx
monicaajmerajain
 
Anti epileptics agents pharmacology
Anti epileptics agents pharmacologyAnti epileptics agents pharmacology
Anti epileptics agents pharmacology
Koppala RVS Chaitanya
 
PH 1.19 ANTIEPILEPTIC DRUGS.pptx
PH 1.19 ANTIEPILEPTIC DRUGS.pptxPH 1.19 ANTIEPILEPTIC DRUGS.pptx
PH 1.19 ANTIEPILEPTIC DRUGS.pptx
Dr. Bushra Hasan Khan
 
Anti epileptic drugs for bpharm sem 4 class
Anti epileptic drugs for bpharm sem 4 classAnti epileptic drugs for bpharm sem 4 class
Anti epileptic drugs for bpharm sem 4 class
KaishAamirPathan
 
4_2019_01_09!10_21_48_PM.ppt
4_2019_01_09!10_21_48_PM.ppt4_2019_01_09!10_21_48_PM.ppt
4_2019_01_09!10_21_48_PM.ppt
Thuyamani M
 
Antiepileptics
Antiepileptics Antiepileptics
Antiepileptics
Naser Tadvi
 
Epilepsy treatment
Epilepsy treatmentEpilepsy treatment
Epilepsy treatment
Medical Students
 
ANTIEPILEPTIC DRUGS 21 12 2005.ppt
ANTIEPILEPTIC DRUGS 21 12 2005.pptANTIEPILEPTIC DRUGS 21 12 2005.ppt
ANTIEPILEPTIC DRUGS 21 12 2005.ppt
Ghost85159
 
ANTIEPILEPTIC_DRUGS .ppt
ANTIEPILEPTIC_DRUGS .pptANTIEPILEPTIC_DRUGS .ppt
ANTIEPILEPTIC_DRUGS .ppt
HarishGorrepati
 
ANTIEPILEPTIC_DRUGS .ppt
ANTIEPILEPTIC_DRUGS .pptANTIEPILEPTIC_DRUGS .ppt
ANTIEPILEPTIC_DRUGS .ppt
ClinicalPharmacist1
 
ANTIEPILEPTIC_DRUGS .pptx
ANTIEPILEPTIC_DRUGS .pptxANTIEPILEPTIC_DRUGS .pptx
ANTIEPILEPTIC_DRUGS .pptx
AlexisIbarra11
 
ANTIEPILEPTIC_DRUGS .ppt a very useful presentation
ANTIEPILEPTIC_DRUGS .ppt a very useful presentationANTIEPILEPTIC_DRUGS .ppt a very useful presentation
ANTIEPILEPTIC_DRUGS .ppt a very useful presentation
DivyaThomas45
 
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,
DrAshok Batham
 
epilepsytreatment-170221173940.pdf
epilepsytreatment-170221173940.pdfepilepsytreatment-170221173940.pdf
epilepsytreatment-170221173940.pdf
UmidjonSaparaliyev
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
mayur kale
 
Antiepileptic drugs ppt drug for CNS phpy
Antiepileptic drugs ppt drug for CNS phpyAntiepileptic drugs ppt drug for CNS phpy
Antiepileptic drugs ppt drug for CNS phpy
NathanDanielgashahun
 

Similar to epilepsy-210211104538.pdf (20)

cns-antiepileptics.pdf
cns-antiepileptics.pdfcns-antiepileptics.pdf
cns-antiepileptics.pdf
 
cns-antiepileptics.pdf
cns-antiepileptics.pdfcns-antiepileptics.pdf
cns-antiepileptics.pdf
 
cns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptxcns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptx
 
recent advances in antiepileptics
recent advances in antiepilepticsrecent advances in antiepileptics
recent advances in antiepileptics
 
Antiepileptic Drugs.pptx
Antiepileptic Drugs.pptxAntiepileptic Drugs.pptx
Antiepileptic Drugs.pptx
 
Anti epileptics agents pharmacology
Anti epileptics agents pharmacologyAnti epileptics agents pharmacology
Anti epileptics agents pharmacology
 
PH 1.19 ANTIEPILEPTIC DRUGS.pptx
PH 1.19 ANTIEPILEPTIC DRUGS.pptxPH 1.19 ANTIEPILEPTIC DRUGS.pptx
PH 1.19 ANTIEPILEPTIC DRUGS.pptx
 
Anti epileptic drugs for bpharm sem 4 class
Anti epileptic drugs for bpharm sem 4 classAnti epileptic drugs for bpharm sem 4 class
Anti epileptic drugs for bpharm sem 4 class
 
4_2019_01_09!10_21_48_PM.ppt
4_2019_01_09!10_21_48_PM.ppt4_2019_01_09!10_21_48_PM.ppt
4_2019_01_09!10_21_48_PM.ppt
 
Antiepileptics
Antiepileptics Antiepileptics
Antiepileptics
 
Epilepsy treatment
Epilepsy treatmentEpilepsy treatment
Epilepsy treatment
 
ANTIEPILEPTIC DRUGS 21 12 2005.ppt
ANTIEPILEPTIC DRUGS 21 12 2005.pptANTIEPILEPTIC DRUGS 21 12 2005.ppt
ANTIEPILEPTIC DRUGS 21 12 2005.ppt
 
ANTIEPILEPTIC_DRUGS .ppt
ANTIEPILEPTIC_DRUGS .pptANTIEPILEPTIC_DRUGS .ppt
ANTIEPILEPTIC_DRUGS .ppt
 
ANTIEPILEPTIC_DRUGS .ppt
ANTIEPILEPTIC_DRUGS .pptANTIEPILEPTIC_DRUGS .ppt
ANTIEPILEPTIC_DRUGS .ppt
 
ANTIEPILEPTIC_DRUGS .pptx
ANTIEPILEPTIC_DRUGS .pptxANTIEPILEPTIC_DRUGS .pptx
ANTIEPILEPTIC_DRUGS .pptx
 
ANTIEPILEPTIC_DRUGS .ppt a very useful presentation
ANTIEPILEPTIC_DRUGS .ppt a very useful presentationANTIEPILEPTIC_DRUGS .ppt a very useful presentation
ANTIEPILEPTIC_DRUGS .ppt a very useful presentation
 
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,
Epilepsy and antiepileptics. Dr.Ashok Kumar Batham,M.D.,
 
epilepsytreatment-170221173940.pdf
epilepsytreatment-170221173940.pdfepilepsytreatment-170221173940.pdf
epilepsytreatment-170221173940.pdf
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
Antiepileptic drugs ppt drug for CNS phpy
Antiepileptic drugs ppt drug for CNS phpyAntiepileptic drugs ppt drug for CNS phpy
Antiepileptic drugs ppt drug for CNS phpy
 

More from Roop

Plan presentation on copd ………………………………….
Plan presentation on copd ………………………………….Plan presentation on copd ………………………………….
Plan presentation on copd ………………………………….
Roop
 
treatment of diabetes mellitus.pptx
treatment of diabetes mellitus.pptxtreatment of diabetes mellitus.pptx
treatment of diabetes mellitus.pptx
Roop
 
HEART FAILURE.pptx
HEART FAILURE.pptxHEART FAILURE.pptx
HEART FAILURE.pptx
Roop
 
NIV.pptx
NIV.pptxNIV.pptx
NIV.pptx
Roop
 
Bladder
Bladder  Bladder
Bladder
Roop
 
8nerve-170112060107.pdf
8nerve-170112060107.pdf8nerve-170112060107.pdf
8nerve-170112060107.pdf
Roop
 
vestibulocochlear nerve dr roop.pdf
vestibulocochlear nerve dr roop.pdfvestibulocochlear nerve dr roop.pdf
vestibulocochlear nerve dr roop.pdf
Roop
 
facial nerve by Dr. Roop
facial nerve  by Dr. Roopfacial nerve  by Dr. Roop
facial nerve by Dr. Roop
Roop
 
Stroke Treatment Protocol.pptx
Stroke Treatment Protocol.pptxStroke Treatment Protocol.pptx
Stroke Treatment Protocol.pptx
Roop
 
seminar 2.pptx
seminar 2.pptxseminar 2.pptx
seminar 2.pptx
Roop
 
MONOCLONAL ANTIBODY.pdf
MONOCLONAL ANTIBODY.pdfMONOCLONAL ANTIBODY.pdf
MONOCLONAL ANTIBODY.pdf
Roop
 
vnd.openxmlformats-officedocument.presentationml.pdf
vnd.openxmlformats-officedocument.presentationml.pdfvnd.openxmlformats-officedocument.presentationml.pdf
vnd.openxmlformats-officedocument.presentationml.pdf
Roop
 

More from Roop (12)

Plan presentation on copd ………………………………….
Plan presentation on copd ………………………………….Plan presentation on copd ………………………………….
Plan presentation on copd ………………………………….
 
treatment of diabetes mellitus.pptx
treatment of diabetes mellitus.pptxtreatment of diabetes mellitus.pptx
treatment of diabetes mellitus.pptx
 
HEART FAILURE.pptx
HEART FAILURE.pptxHEART FAILURE.pptx
HEART FAILURE.pptx
 
NIV.pptx
NIV.pptxNIV.pptx
NIV.pptx
 
Bladder
Bladder  Bladder
Bladder
 
8nerve-170112060107.pdf
8nerve-170112060107.pdf8nerve-170112060107.pdf
8nerve-170112060107.pdf
 
vestibulocochlear nerve dr roop.pdf
vestibulocochlear nerve dr roop.pdfvestibulocochlear nerve dr roop.pdf
vestibulocochlear nerve dr roop.pdf
 
facial nerve by Dr. Roop
facial nerve  by Dr. Roopfacial nerve  by Dr. Roop
facial nerve by Dr. Roop
 
Stroke Treatment Protocol.pptx
Stroke Treatment Protocol.pptxStroke Treatment Protocol.pptx
Stroke Treatment Protocol.pptx
 
seminar 2.pptx
seminar 2.pptxseminar 2.pptx
seminar 2.pptx
 
MONOCLONAL ANTIBODY.pdf
MONOCLONAL ANTIBODY.pdfMONOCLONAL ANTIBODY.pdf
MONOCLONAL ANTIBODY.pdf
 
vnd.openxmlformats-officedocument.presentationml.pdf
vnd.openxmlformats-officedocument.presentationml.pdfvnd.openxmlformats-officedocument.presentationml.pdf
vnd.openxmlformats-officedocument.presentationml.pdf
 

Recently uploaded

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 

Recently uploaded (20)

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 

epilepsy-210211104538.pdf

  • 2. What is EPILEPSY? Epilepsy is a chronic CNS disorder characterized by brief episodes of Seizure is a sudden time limited involuntary alteration of behavior with or without loss of consciousness accompanied by an 2
  • 3. Pathophysiology of EPLILEPSY • Each individual neuron is linked with hundreds of other neuron via synapses. • Neurons discharge electrical current and neurotransmitters are released at synaptic levels and permits inter-communication. • There are two types of Neurotransmitters: 1. Inhibitory Neurotransmitters: GABA (Gamma amino butyric acid) acts on ion channels and increases chloride outflow and decreases chances of action potential. 2. Excitatory Neurotransmitters: Glutamate and Aspartate allows sodium and calcium influx which paves way for action potential formation.
  • 4. • Seizures occur due to the imbalance between the inhibitory and excitatory Neurotransmitters. • A normal neuron discharges repetitively at low baseline frequencies. If neurons are damaged, injured/ suffer a chemical/ metabolic insult, the changes in discharge pattern develops. • During epilepsy, regular low frequency discharges are replaced by bursts of high frequency discharges followed by periods of inactivity. • A single Neuron discharging in an abnormal manner is usually not clinically significant. But when a whole population of neurons discharge synchronously in an abnormal manner, epileptic seizure occurs.
  • 5. Causes of EPLILEPSY • In 28% cases, cause can be determined, in rest 72% cases, cause is idiopathic. • Determined causes: 1) Inherited genetic 2) Acquired: Trauma, Metabolic infections, Tumour, Neuro surgery, Drugs, etc. of inhibitory neurotransmitter such as the 4) Increase excitatory neurotransmitter.
  • 6. 5) Concentration of is reversed. 6) Abnormality in the potassium conductance. 7) Defect in the voltage sensitive channel 6
  • 7. Drugs that Induces Seizures • Alcohols: ethanol, ethylene glycol, methanol, propylene glycol • Anesthetics: bupivacaine, cocaine, lidocaine, procaine, proparacaine, enflurane, etomidate, isoflurane, ketamine. • Antibiotics: cephalosporins,ciprofloxacin, gentamicin, cilastatin, isoniazid • Anticholinergics: atropine, benztropine mesylate, diphenhydramine • Antidepressants: amitriptyline, amoxapine, clomipramine, desipramine,doxepin • Antihistamines: astemizole, brompheniramine, chlorpheniramine, diphenhydramine, doxylamine
  • 8. • Antineoplastics: bleomycin, busulphan, carmustine, chlorambucil, cisplatin,cytarabine,mechlorethamine • Antiparasitics: chloroquine, oxamniquine, pyrimethamine • Antivirals: acyclovir, amantadine • Asphyxiants: acetylene, butane, carbon dioxide, ethane • Cardiovascular Agents: aprindine, digoxin, lidocaine, lorcainide. • Drugs Of Abuse: amphetamines, cocaine, lysergic acid diethylamide (LSD), marijuana, methamphetamine ("ice"), phencyclidine (PCP) • Drug Withdrawal: anticonvulsants,barbiturates, benzodiazepines
  • 9. Diagnosis • Neurological examination/ Neuropsychological Tests • Medical history • Genetic Testing • Electroencephalogram (EEG) • CT Scan/ MRI Scan • fMRI • Positron Emission Tomography (PET Scan) • SPECT (Single Photon Emission Computerized Tomography) • SISCOM (Subtraction Ictal SPECT categorized to MRI)
  • 10. Types of epilepsy Generalized seizures Tonic – clonic seizure (Gran mal seizure) Absence seizure (petit mal seizure) Atonic seizure Myoclonic seizure Localized (partial or focal) Simple partial seizure (jacksoninan) Complex partial (psychomotor) seizure 10
  • 11. Types of EPLILEPSY • Generalized seizures 1.Tonic-clonic seizures(Major epilepsy, Grand mal) • Lasts 1-2 min • Usual sequences is aura-cry- unconsciousness-tonic of all body muscles-clonic followed by prolong sleep • Stiffening of arms and legs followed by rhythmic jerking.
  • 12. Types of EPLILEPSY 2. Absence siezures (Minor epilepsy, Petit mal) • Lasts about 1-2 min • Momentary loss of consciousness • Little jerking • Often subside prior to puberty.
  • 13. Types of EPLILEPSY 3. Atonic seizures (Akinetic epilepsy) • Unconsciousness with relaxation of all muscles • Due to excessive • Patient may fall , after 10 seconds to a minute, they recover and regain consciousness and can stand and walk again.
  • 14. Types of EPLILEPSY 4. Myoclonic seizures of muscles of limb or the whole body • Juvenile myoclonic epilepsy (JME) is the most common form of this condition.
  • 15. Types of Epilepsy • Simple partial seizure(Cortical focal epilepsy) oLasts 1/ 1-2 min oConvulsion are of muscles or localized sensory disturbance depending on the area of cortex involved in seizure oWithout loss of consciousness oComplex partial seizure(Temporal lobe epilepsy, Psychomotor epilepsy) oAttack of bizarre and and purposeless movement oEmotional changes lasting 1-2 min along with impairment of consciousness. oThe seizure focus is located in the temporal lobe. 15
  • 16. TYPES OF TREATMENT 16 • Medication • Surgery • Non-pharmacologic treatment 1. Ketogenic diet 2. Vagus nerve stimulation (VNS) 3. Lifestyle modifications
  • 17. CLASSIFICATION 1. Barbiturate: Phenobarbitone 2. Deoxybarbiturate: Primidone 3. Hydantoin: Phenytoin, Fosphenytoin 4. Iminostilbene: Carbamazepine, Oxcarbazepine 5. Succinimide: Ethosuximide 6. Aliphatic carboxylic acid: Valproic acid (sodium valproate) 7. Benzodiazepines: Clonazepam, Diazepam, Lorazepam, Clobazam 8. Phenyltriazine: Lamotrigine 9. Cyclic GABA analogue: Gabapentin 10. Newer drugs: Vigabatrin, Topiramate, Tiagabine, Zonisamide, Levetiracetam 17
  • 18. CLASSIFICATION • Group 1- Blockade of voltage-dependent Na+ or Ca channels (generalised and partial seizures) • Group 2- Enhance inhibitory events mediated by GABA (absence, generalised, partial seizures) • Group 3- Blocks T-type calcium channels (absence seizures). • Group X- Reduce events mediated by excitatory amino acid glutamate
  • 20. Group 1- Blockade of voltage-dependent Na+ or Ca channels (generalised and partial seizures) 20
  • 21. Carbamazepine Clinical uses: • Primary generalized tonic clonic seizures. • Partial seizures with or without secondarily generalization. • Bipolar disorders. • Chronic pain syndromes: Trigeminal neuralgia. Pharmacokinetics: • Initial half-life is 20- 40 hrs but decreases to 20-40 hr on chronic medication. • Active metabolite: 10-11 epoxy carbamazepine.
  • 22. Carbamazepine Dose: • Available only in oral form. • Effective in children, in whom a dosage of 15-25 mg/kg/d is appropriate. • In adults, daily doses of 1 g or even 2 g are tolerated. Neurotoxic side effects : • Blurred or double vision • Lethargy, headache. • Worsening of myoclonic, Atonic & absence seizures.
  • 23. Carbamazepine Systemic side effects : • Nausea, vomiting, diarrhea • Hyponatremia & fluid retention. • Rash, pruritus Rare side effects : • Blood dyscrasias: Agranulocytosis, aplastic anemia. • Dermatitis/rash • Stevens-Johnson syndrome. • Serum sickness, pancreatitis • Hepatic failure
  • 24. Phenytoin Clinical uses : • Partial & generalized tonic clonic seizures. • 2nd line agent for patients with mixed seizures (myoclonic/tonic- clonic). • Status epilepticus. Neurotoxic Side effects: • Dose related : Diplopia & Ataxia. • Peripheral neuropathy. • Behavior changes.
  • 25. Phenytoin Systemic side effects : • Skin rash • Lymphadenopathy ( abnormally enlarged lymph nodes) • Gingival hyperplasia • Pulmonary fibrosis • Hirsutism • Teratogenic ( Fetal Hydantoin syndrome includes cleft lip and palate, congenital heart disease) • Megaloplastic anemia ( folate deficiency ). NOTE – phenytoin is also an anti-arrthymetic drug treatment with phenytoin should not be stopped abruptly.
  • 26. Lamotrigine Decreases the release of excitatory neurotransmitters (glutamate/aspartate). Clinical uses : • Monotherapy in partial seizures • Adjunctive therapy in generalized tonic clonic seizure • Mixed seizures Side effects : • Dizziness, headache, Diplopia • Nausea • Hypersensitivity skin rash not to be used in those < 16 years
  • 27. Oxcarbazepine It is a 10- keto analogue to carbamazepine. Clinical uses: • Partial seizures • Generalized tonic clonic seizures • Affective disorders • Trigeminal neuralgia Side effects : • CNS : sedation, dizziness, ataxia, diplopia • Hyponatremia but less less than carbamazepine • Allergic skin reaction
  • 28. Zonisamide • Sulfonamide derivatives. • Blocking of voltage dependent Na & T- type Ca channels. • Partial & Generalized tonic clonic seizures. • Useful against infantile spasm and certain types of myoclonias. Side effects : • CNS: confusion, ataxia, sedation, poor concentration • Anorexia & weight loss • Skin rash • decreased sweating, hyperthermia • Renal stones (rare) C/I : Allergy to sulfonamides.
  • 29. • Group 2- Enhance inhibitory events mediated by GABA (absence, generalised, partial seizures) 29
  • 30. Phenobarbital M.O.A : • Binds to GABA receptor improving its effect by extending GABA mediated chloride channel opening. Clinical uses: • Partial seizures • Generalized tonic clonic seizures • Neonatal seizures • Status epilepticus Side effects: • Sedation, ataxia, nystagmus ( rapid, rhythmic and involuntary eye movements), vertigo • Agitation & confusion, at high doses. • Alteration of sleep cycles
  • 31. Gabapentin It is an amino acid, an analogue to GABA. Clinical uses: • Partial seizures • Generalized tonic clonic seizures • Neuropathic pain: post herpetic neuralgia Side effects: • CNS: sedation, ataxia, headache, tremor • GI upset. • Weight gain.
  • 32. Tiagabine Inhibition of GABA reuptake into presynaptic neurons. Clinical uses: • Adjunctive treatment for partial and generalized seizures Side effects: • CNS: sedation, tremor, depression, confusion • Nausea, abdominal pain • Not recommended in children under age of 12 years.
  • 33. Vigabatrin • Irreversible inhibitor of GABA transaminase. Clinical uses: • 2nd line treatment in patients with refractory partial seizures • 1st line treatment in infantile spasm (west’s syndrome) • May worsen myoclonic jerks and generalized absence and precipitate status epilepticus Side effects : • CNS: sedation, dizziness, headache • Change in mood, agitation • Retinal toxicity… irreversible • Weight gain
  • 34. Clonazepam Clinical uses • Myoclonic seizures • Generalized seizures (mainly absence) • Status epilepticus • Infantile spasm Side effects: • Sedation, ataxia, irritability. • Cardiovascular & Respiratory depression . • Hyper salivation in pediatric . • Idiosyncratic reaction like blood dyscrasia is rare.
  • 35. Group 3- Blocks T-type calcium channels (absence seizures). 35
  • 36. Ethosuximide • Reduces T- type calcium currents in thalamic neurons • Effective against absence seizures • May increase tonic- clonic seizures Side effects : • Nausea & Vomiting. • Sleep disturbances. • Drowsiness & Hyperactivity.
  • 37. Drugs With Multiple Mechanisms Of Actions ● Valproate ● Felbamate ● Topiramate
  • 38. Valproate M.O.A: • Blocking voltage- dependent sodium channels • Enhances GABA synthesis • Inhibits GABA transaminase • Acts against T- type calcium current Clinical uses: • Absence seizures • Generalized tonic clonic seizures • Bipolar disorders • Migraine prophylaxis
  • 39. Valproate Side effects: • CNS: Tremor • Dose related GI symptoms • Increase appetite & weight gain • Hair loss • Hepatotoxicity esp. < 2 years. • Thrombocytopenia • Teratogenic, spina bifida ( major birth defect, type of neural tube defect
  • 40. Felbamate M.O.A: • Inhibition of voltage – dependent sodium channels • Potentiate GABA response at GABA receptors • Inhibition of the excitatory N-methyl-D-aspartate (NMDA) receptors Clinical uses: • Broad spectrum of action • Effective in some patients with partial seizures • 3rd line drug in refractory seizures- in lennox gastaut syndrome Side effects: • CNS: Insomnia, Diplopia, Ataxia • Weight loss.
  • 41. Topiramate M.O.A: • Blockage voltage – dependent sodium channels • Enhances activity of GABA at non benzodiazepine • Site on GABA (A) receptors • Antagonizes NMDA receptors • Weakly inhibits carbonic anhydrase enzyme Clinical uses: • Adjunctive therapy for partial & generalized seizures • Adjunctive therapy for Lennox-Gastaut syndrome & infantile spasm
  • 42. Topiramate Side effects: • CNS: confusion, ataxia, poor concentration • Cognitive impairment • Visual disorders: myopia, glaucoma (rare) • Weight loss • Parasthesia & renal stones due to inhibition of carbonic anhydrase enzyme. • Teratogenic in animals
  • 43. Drugs With Unknown Mechanism Of Actions Levetiracetam: • Broad spectrum • Add- on therapy for refractory partial seizures Side effects: • CNS: Fatigue, dizziness, agitation, anxiety • Increases susceptibility to infection, rhinitis or flu like symptoms • Anemia, leukopenia
  • 44. Pregabalin Clinical uses: • Adjunctive therapy for partial seizures • Peripheral neuropathic pain. Renally excreted and is not hepatically metabolized Side effects : • Dizziness, somnolence and ataxia • Blurred or double vision • Weight gain • Peripheral edema • May cause euphoria • New onset myoclonus has been reported
  • 45. ECT 45 • Electroconvulsive therapy (ECT), formerly known as electroshock therapy, and often referred to as shock treatment, is a psychiatric treatment in which seizures are electrically induced in patients to provide relief from mental disorders.
  • 46. KETOGENIC DIET 46 • Based on finding that starvation, which burns fat for energy has an antiepileptic effect • Used primarily to treat severe childhood epilepsy, has been effective in some adults & adolescents • High fat, low carbohydrate and protein intake • Requires strong family commitment
  • 47. VAGUS NERVE STIMULATION 47 • Device is implanted to control seizures by delivering electrical stimulation to the vagus nerve in the neck, which relays impulses to widespread areas of the brain. • Used to treat partial seizures when medication does not work.
  • 48. COMMON CAUSES OF FAILURE OF ANTIEPILEPTICS 1. Improper diagnosis of the type of seizures 2. Incorrect choice of drug 3. Inadequate or excessive dosage 4. Poor compliance 48
  • 49. TREATMENT IN SPECIAL SITUATIONS ANTIEPILEPTIC AND PREGNANCY : • Seizures are very harmful for pregnant women. • Monotherapy usually better than drugs combination. • Folic acid is recommended to be given for every pregnant women with epilepsy. • Phenytoin, sodium valproate are absolutely contraindicated and oxcarbamazepine is better than carbamazepine. 49
  • 50. EPILEPSY IN ADOLESCENTS AND YOUNG ADULTS Important points to remember are: • Avoiding sleep deprivation, • alcohol and substance abuse, driving, potentially risky leisure activities like rock climbing, horse riding, etc. • Prolonged television (TV) viewing, playing video games and dancing in dark rooms with flickering/flashing lights (discotheques). 50
  • 51. SURGERY IN EPILEPSY • All patients with medically intractable epilepsy (MIE) should be evaluated at a center performing epilepsy surgery. • A patient having MIE with an identifiable lesion on imaging, correlated with electrophysiology [Electroencephalogram (EEG)] is a potential candidate for epilepsy surgery. Even if imaging is negative, patients still can be surgical candidates on further investigation. • Epilepsy surgery should be done only in specialized centers. • Surgery has a high chance of achieving seizure freedom (in 60– 70% of cases) and a reduction in seizure frequency in the remaining 30–40% cases. • When indicated it should be considered as early as feasible rather than an option of last resort. 51
  • 52. SURGERY IN EPILEPSY • Epilepsy surgery may be resective or nonresective. • Resective surgery includes lesionectomy (resection of the lesion and the surrounding epileptogenic area), amygdalohippocampectomy with or without temporal lobe resection, multilobar resection and hemispherectomy. • Nonresective surgery includes multiple subpial transections corpus colostomy and vagus nerve stimulation (VNS). 52
  • 54. Pathophysiology Decrease in INT/Increase in ENT/Abnormalities in Ion channel Rhythmic and repetitive hyper synchronous discharge of neuron Seizures Repetitive Seizures Epilepsy
  • 55. 55
  • 56.
  • 57. 57
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63. 63